ICU Medical, Inc. (NASDAQ:ICUI) Shares Bought by Prudential Financial Inc.

Prudential Financial Inc. increased its position in ICU Medical, Inc. (NASDAQ:ICUI) by 7.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 82,059 shares of the medical instruments supplier’s stock after buying an additional 5,795 shares during the period. Prudential Financial Inc.’s holdings in ICU Medical were worth $12,733,000 as of its most recent SEC filing.

A number of other institutional investors have also modified their holdings of ICUI. Intech Investment Management LLC acquired a new position in ICU Medical in the 3rd quarter valued at $815,000. Charles Schwab Investment Management Inc. increased its stake in ICU Medical by 10.2% in the third quarter. Charles Schwab Investment Management Inc. now owns 301,107 shares of the medical instruments supplier’s stock valued at $54,868,000 after purchasing an additional 27,927 shares during the last quarter. Citigroup Inc. increased its stake in ICU Medical by 100.4% in the third quarter. Citigroup Inc. now owns 28,965 shares of the medical instruments supplier’s stock valued at $5,278,000 after purchasing an additional 14,512 shares during the last quarter. Cerity Partners LLC lifted its position in ICU Medical by 33.2% during the third quarter. Cerity Partners LLC now owns 9,846 shares of the medical instruments supplier’s stock worth $1,794,000 after buying an additional 2,454 shares during the period. Finally, FMR LLC boosted its stake in ICU Medical by 2,676.6% in the 3rd quarter. FMR LLC now owns 104,094 shares of the medical instruments supplier’s stock worth $18,968,000 after buying an additional 100,345 shares during the last quarter. Institutional investors and hedge funds own 96.10% of the company’s stock.

Insiders Place Their Bets

In related news, CEO Vivek Jain sold 1,373 shares of the company’s stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $155.48, for a total transaction of $213,474.04. Following the completion of the sale, the chief executive officer now directly owns 104,593 shares of the company’s stock, valued at approximately $16,262,119.64. This represents a 1.30 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 6.70% of the stock is owned by insiders.

ICU Medical Stock Down 3.0 %

ICUI opened at $144.28 on Friday. ICU Medical, Inc. has a 1 year low of $93.36 and a 1 year high of $196.26. The firm has a 50 day moving average price of $154.89 and a 200 day moving average price of $164.01. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.03 and a current ratio of 2.29. The company has a market cap of $3.54 billion, a PE ratio of -31.57 and a beta of 0.73.

Analyst Ratings Changes

A number of research firms have recently commented on ICUI. StockNews.com downgraded shares of ICU Medical from a “buy” rating to a “hold” rating in a research note on Thursday. Raymond James set a $97.00 price target on shares of ICU Medical in a research report on Wednesday, March 12th. Finally, Jefferies Financial Group upgraded shares of ICU Medical from a “hold” rating to a “buy” rating and set a $200.00 price target on the stock in a report on Wednesday, December 11th. Two equities research analysts have rated the stock with a hold rating, two have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $168.67.

ICU Medical Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.